Aligos Therapeutics Inc (ALGS)

Aligos Therapeutics Inc Azioni (ALGS) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	100.00%-	2.83	0.17	0.74	0.97
	0.31%29.67	29.76	21.98	29.10	19.53
Research and Development	2.99%24.05	23.35	17.04	23.94	13.98
Operating Income/Loss	92.98%-1.89	-26.93	-21.81	-28.36	-18.57
Net Interest Income/Expense	100.00%0.20	0.10	0.60	0.40	0.40
Income/Loss From Continuing Operations Before Tax	105.75%1.31	-22.72	-19.85	-31.48	-15.68
Income Tax Expense/Benefit	786.75%2.81	0.32	0.03	0.06	0.19
	93.47%-1.50	-23.04	-19.88	-31.54	-15.86
Attributable To Parent	93.47%-1.50	-23.04	-19.88	-31.54	-15.86
Basic Average Shares	0.27%10.43	10.40	0.17	10.37	10.35
Diluted Average Shares	0.27%10.43	10.40	0.17	10.37	10.35
Basic Earnings Per Share	93.67%-0.14	-2.21	-2.01	-3.04	-1.53
Diluted Earnings Per Share	93.67%-0.14	-2.21	-2.01	-3.04	-1.53